Johanna M. P. van den Hout

Author

Also Known As

J. M. P. Van den Hout, J. M. P. van den Hout, J.M.P. Hout, J.M.P. van den Hout, Johanna M P van den Hout, Johanna M. P. Van Den Hout, Johanna M. P. Van den Hout, Johanna M. P. van den Hout, Johanna M.P. Van den Hout, Johanna M.P. van den Hout

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus MC - Sophia Children’s Hospital KU Leuven Erasmus University Rotterdam University of Groningen

About

Johanna M. P. van den Hout is an author at Erasmus MC specializing in pediatrics, dementia, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	60
2	Social Sciences	2	2	60
3	Neurology	2	2	60
4	Neuroscience	2	2	60
5	Psychiatry	1	1	16

Johanna M. P. van den Hout

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From Milk Johanna M. P. van den Hout, Joep H. J. Kamphoven, Léon P. F. Winkel, PEDIATRICS	2004	348
Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐up Léon P. F. Winkel, Johanna M. P. van den Hout, Joep H. J. Kamphoven, Annals of Neurology	2004	230
Enzyme therapy for Pompe disease with recombinant human α‐glucosidase from rabbit milk Johanna M. P. van den Hout, Arnold Reuser, J. B. C. de Klerk, Journal of Inherited Metabolic Disease	2001	173
Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain Berendine J. Ebbink, Esther Poelman, Femke K. Aarsen, Developmental Medicine & Child Neurology	2018	104
Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy Berendine J. Ebbink, Femke K. Aarsen, Carin M. Van Gelder, Neurology	2012	74
Childhood Pompe disease: clinical spectrum and genotype in 31 patients Carine I. van Capelle, Jan C. van der Meijden, Johanna M. P. van den Hout, Orphanet Journal of Rare Diseases	2016	63
Cognitive decline in classic infantile Pompe disease: An underacknowledged challenge Berendine J. Ebbink, Esther Poelman, Iris Plug, Neurology Enzyme Replacement TherapyNeurological DisorderCorticobasal DegenerationMotor DevelopmentSubstrate Reduction Therapy	2016	44
Cardiac outcome in classic infantile Pompe disease after 13 years of treatment with recombinant human acid alpha-glucosidase Carine I. van Capelle, Esther Poelman, Ingrid M.E. Frohn-Mulder, International Journal of Cardiology	2018	41
High Sustained Antibody Titers in Patients with Classic Infantile Pompe Disease Following Immunomodulation at Start of Enzyme Replacement Therapy Esther Poelman, Marianne Hoogeveen‐Westerveld, Marian A. Kroos-de Haan, The Journal of Pediatrics	2018	34
Effects of higher and more frequent dosing of alglucosidase alfa and immunomodulation on long‐term clinical outcome of classic infantile Pompe patients Esther Poelman, Jan J. A. van den Dorpel, Marianne Hoogeveen‐Westerveld, Journal of Inherited Metabolic Disease	2020	34

Page 1